MGAT5 and liver cancer: In liver cancer the majority of aberrations are the changes in the activity of N-acetylglucosaminyltransferase III (GnT-III) and N-acetylglucosaminyltransferase V (GnT-V), which respond to formation of branching and addition of bisecting GlcNAc [6].